1. Kawai, Yuko, Nagayama, Aiko, Miyao, Kazuhiro, Hayashida, Tetsu, Kitagawa, Yuko. 2024. A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer. In Breast cancer (Tokyo, Japan), 32, 120-131. doi:10.1007/s12282-024-01641-y. https://pubmed.ncbi.nlm.nih.gov/39352623/
2. Doçi, Colleen L, Mikelis, Constantinos M, Lionakis, Michail S, Molinolo, Alfredo A, Gutkind, J Silvio. 2015. Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma. In Cancer research, 75, 2937-48. doi:10.1158/0008-5472.CAN-14-3121. https://pubmed.ncbi.nlm.nih.gov/25952650/
3. Kusy, Sophie, Potiron, Vincent, Zeng, Chan, Drabkin, Harry A, Roche, Joëlle. . Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. In Biochimica et biophysica acta, 1730, 66-76. doi:. https://pubmed.ncbi.nlm.nih.gov/16005989/
4. Ying, Yufan, Wu, Yuqing, Zhang, Fenghao, Zheng, Xiangyi, Xie, Liping. 2024. Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer. In Molecular cancer, 23, 79. doi:10.1186/s12943-024-01994-0. https://pubmed.ncbi.nlm.nih.gov/38658974/
5. Ye, Ke, Ouyang, Xiwu, Wang, Zhiming, Yao, Lei, Zhang, Gewen. 2020. SEMA3F Promotes Liver Hepatocellular Carcinoma Metastasis by Activating Focal Adhesion Pathway. In DNA and cell biology, 39, 474-483. doi:10.1089/dna.2019.4904. https://pubmed.ncbi.nlm.nih.gov/31968181/
6. Liu, Yi, Li, Ronghua, Yin, Kai, Ren, Gang, Zhang, Yongdong. 2017. The crucial role of SEMA3F in suppressing the progression of oral squamous cell carcinoma. In Cellular & molecular biology letters, 22, 32. doi:10.1186/s11658-017-0064-y. https://pubmed.ncbi.nlm.nih.gov/29299034/
7. Moragas, Núria, Fernandez-Nogueira, Patricia, Recalde-Percaz, Leire, Carbó, Neus, Fuster, Gemma. 2024. The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma. In Breast cancer research : BCR, 26, 122. doi:10.1186/s13058-024-01871-0. https://pubmed.ncbi.nlm.nih.gov/39138514/
8. Regano, Donatella, Visintin, Alessia, Clapero, Fabiana, Serini, Guido, Giraudo, Enrico. 2017. Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program. In Arteriosclerosis, thrombosis, and vascular biology, 37, 1710-1721. doi:10.1161/ATVBAHA.117.308226. https://pubmed.ncbi.nlm.nih.gov/28729362/
9. Aigrot, Marie-Stéphane, Barthelemy, Clara, Moyon, Sarah, Lubetzki, Catherine, Tepavčević, Vanja. 2022. Genetically modified macrophages accelerate myelin repair. In EMBO molecular medicine, 14, e14759. doi:10.15252/emmm.202114759. https://pubmed.ncbi.nlm.nih.gov/35822550/
10. Li, Qiong, Ma, Naya, Li, Xinlei, Zhang, Xi, Rao, Jun. 2023. Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway. In Chinese medical journal, 136, 1448-1458. doi:10.1097/CM9.0000000000002686. https://pubmed.ncbi.nlm.nih.gov/37114652/
智鼠故事 
